Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Trends 2025–2029: Forecasts for Key Growth Segments
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Expected To Expand Between 2025 And 2029?
The messenger ribonucleic acid (mrna) synthesis raw materials market size has experienced modest growth in recent years. It is forecast to increase from $2.99 billion in 2024 to $3.03 billion in 2025, achieving a compound annual growth rate (CAGR) of 1.5%. This historical expansion can be attributed to advancements in biomedical research, a growing interest in vaccines and therapeutics, the necessity for personalized medicine, initiatives in outbreak preparedness and response, and the expansion of the biotech industry.
The messenger ribonucleic acid (mrna) synthesis raw materials market size is projected to experience consistent expansion over the upcoming years. This market is forecast to reach $3.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.5%. Key factors driving this growth during the projected timeframe include optimized supply chains, increased commercialization and broader market penetration, substantial investments in biotechnology and pharmaceuticals, supportive regulatory frameworks and approvals, and the expansion of therapeutic applications. Significant trends anticipated in this forecast period encompass the emergence of new participants, enhanced focus on quality control and standardization, developments in intellectual property and licensing, efforts toward global access and equity, and a transition to more sustainable and scalable manufacturing processes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
Which Drivers Are Supporting Growth Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The increasing occurrence of cancer and persistent health conditions is anticipated to drive the expansion of the mRNA synthesis raw materials market. Cancer is characterized by the unregulated proliferation of abnormal cells, capable of invading adjacent tissues and potentially spreading throughout the body through the bloodstream and lymphatic systems. Chronic disorders are generally defined as health issues lasting a year or more, requiring ongoing medical care, interfering with daily life, or exhibiting both characteristics. These raw materials for mRNA synthesis find application in drug discovery, vaccine creation, and the production of RNA-based therapeutics, which provide enhanced immunogenicity, greater efficacy, and quicker production cycles for addressing cancer and chronic conditions. As an illustration, the American Cancer Society Facts and Figures, a US-based professional organization, reported that in 2022, roughly 1.9 million new cancer cases were identified in the US, leading to 609,360 fatalities. For 2023, forecasts indicate a minor rise to more than 1.9 million new cases and around 609,820 deaths. Consequently, the rising prevalence of cancer and chronic illnesses fuels the demand for mRNA synthesis raw materials.
What Are The Primary Types Of Segments Analyzed In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Which Ongoing Trends Are Expected To Shape The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Outlook?
Product innovations have become a prominent and increasingly popular trend within the mRNA synthesis raw materials market. Major entities engaged in the mRNA synthesis raw materials market are focused on developing cutting-edge products to solidify their competitive position. As an illustration, in September 2022, Thermo Fisher Scientific, a US-based firm specializing in instrumentation, reagents, consumables, and software services, unveiled its Dynabeads Solutions. These beads are engineered to enable the scaling of GMP-grade synthesis and purification of mRNA for vaccine development. Specifically, Dynabeads Streptavidin for In Vitro Transcription are intended for straightforward solid-phase IVT of cell-free mRNA and allow the DNA template to be utilized up to six times, thereby decreasing the effort needed for plasmid creation while boosting mRNA yield on scales ranging from g to g. Moreover, this will aid in devising an optimized pipeline, empowering mRNA companies to transition more rapidly from the development phase to commercialization.
Who Are The Prominent Global Companies Shaping The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Download The Full Report For Exclusive Market Findings:
What Are The Key Regional Factors Influencing The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp
Browse Through More Reports Similar to the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market 2025, By The Business Research Company
Rna Targeting Small Molecules Therapeutics Global Market Report 2025
Antisense And Rnai Therapeutics Global Market Report 2025
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
